Early Access — free while we kick the tires
EdgarHawk

Huber Reid M

Director

Director
1 filing analyzed · 1 company · Latest 2025-09-15

Companies

Company Buys Sells Direction
Rapport Therapeutics, Inc. RAPP 1 0 Net buying

Activity

September 2025
high
Buy
20,400 shares
$499,374
Significance 7/10

Director Huber Reid M buys 20,400 RAPP shares at $24.48; cluster of 3 insiders buying within 14 days as stock rallies +68.2% in 30 days

Director Huber Reid M purchased 20,400 shares at $24.48, establishing an initial position of 20,400 shares. The transaction is part of a cluster buy pattern with 2 other insiders purchasing within the past 14 days. The stock has risen sharply (+68.2% over 30 days, +125.8% over 90 days) from a 52-week low of $7.15, though it remains 21.4% below its 52-week high of $31.47. The company reported a negative net income of $-26,732,000.00 for its most recent full fiscal year, so management is deploying capital to acquire equity stakes in an unprofitable business during a significant rally phase. The multi-insider purchase pattern during strong upward momentum, combined with the company's unprofitable fundamentals, warrants observation of whether this represents confidence in a turnaround or positioning ahead of potential announcements.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access